Vancouver-based AbSci raises $15.4M in Series D funding
Vancouver-based biotechnology company AbSci announced Tuesday that it has secured $10.4 million in Series D financing, plus $5 million in term debt. The round was led by KBI Biopha…
More from Southwest Washington
Columbian | Vancouver
Prep Highlights: Skyview slowpitch reaches tri-district title game to clinch state berth
Southwest Washington
•
1m ago
Columbian | Vancouver
Proposed conflict-of-interest rule would impact Vancouver's Culture, Arts and Heritage Commission
Southwest Washington
•
5h ago
Columbian | Vancouver
Worlds more habitable than Earth? They're out there
Southwest Washington
•
7h ago
Columbian | Vancouver
Gardening With Allen: Fall perfect time for planting shrubs and trees
Southwest Washington
•
7h ago
Columbian | Vancouver
Battle Ground cross country runner Lord King Nana-Badu-Weah excels in Air Force-sponsored aviation program
Southwest Washington
•
7h ago